Possible better long-term survival in left versus right-sided colon cancer - A systematic review

Danish Medical Journal

Volumn 59, Issue 6, 2012, Pages

  Hansen, Iben Onsberg ^a   Jess, Per ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

AGE; CANCER PROGNOSIS; CANCER STAGING; COLON CANCER; COMORBIDITY; EMERGENCY; GENDER; GENE MUTATION; HUMAN; LONG TERM SURVIVAL; METASTASIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MORTALITY; MULTICENTER STUDY (TOPIC); PROTEIN EXPRESSION; REVIEW; RISK; SCORING SYSTEM; SYSTEMATIC REVIEW; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME; COLON; COLON TUMOR; PATHOLOGY; PROGNOSIS; SEX DIFFERENCE; SURVIVAL RATE;

AGE FACTORS; COLON; COLONIC NEOPLASMS; COMORBIDITY; HUMANS; PROGNOSIS; SEX FACTORS; SURVIVAL RATE;

EID: 84873270711     PISSN: None     EISSN: 22451919     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal location. Ann Int Med 1990;113:779-88.
2. Benedix F, Kube R, Meyer F et al. Comparison of 17,641 patients with right-and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53:57-64.
3. Elnatan J, Gosh HS, Smith DR. C-KI-RAS activation and the biological behaviour of proximal and distal colonic adenocarcinomas. Eur J Cancer 1996;32A:491-7.
4. Hutchins G, Southward K, Handley K et al. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 2011;29:1261-70.
5. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses. The PRISMA statement. PLoS Med 2009;6:e1000097.
6. Gervaz P, Bouzourene H, Certtini JP et al. Distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon and Rectum 2001;44:363-73.
7. Gatta G, Ciccolallo L, Capocaccia R et al. Differences in colorectal cancer survival between European and US populations: the importance of subsite and morphology. Eur J Cancer 2003;39:2214-22.
8. Nawa T, Kato J, Kawamoto H et al. Differences between right-and leftsided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 2008;23:418-23.
9. Benedix F, Schmidt U, Mroczkowski P et al. Colon carcinoma-classification into right and left-sided cancer or according to colonic subsite? Analysis of 29,568 patients. Eur J Surg Oncol 2011;37:134-9.
10. Suttie SA, Shaikh I, Mullen R et al. Outcome of right-and left-sided colonic and rectal cancer following surgical resection. Colorectal Dis 2011;13: 884-9.
11. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM et al. Colon cancer in France: evidence for improvement in management and survival. Gut 2002;51:60-4.
12. Angell-Andersen E, Tretli S, Coleman MP et al. Colorectal cancer survival trends in Norway 1958-1997. Eur J Cancer 2004;40:734-42.
13. Meguid RA, Slidell MB, Wolfgang CL et al. Is there a difference in survival between right-versus left-sided colon cancers? Ann Surg Oncol 2008;15:2388-94.
14. Wray CM, Ziogas A, Hinojosa MW et al. Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis. Dis Colon Rectum 2009;52:1359-66.
15. Christodoulidis G, Spyridakis M, Symeonidis D et al. Clinicopathological differences between right-and left-sided colonic tumors and impact upon survival. Tech Coloproctol 2010;14:45-7.
16. Hemminki K, Santi I, Weires M et al. Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer 2010;10:688.
17. Meza R, Jeon J, Renehan AG et al. Colorectal cancer incidence trends in the United States and United Kingdom: Evidence of right-to left sided biological gradients with implications for screening. Cancer Res 2010;70:5419-29.
18. Snaebjornsson P, Jonasson L, Jonsson T et al. Colon cancer in Iceland-a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients age. Int J Cancer 2010;127:2645-53.
19. Derwinger K, Gustavsson B. Variations in demography and prognosis by colon cancer location. Anticancer Res 2011;31:2347-50.
20. Weiss JM, Pfau PR, O'Connor ES et al. Mortality by stage for right-vesus left-sided colon cancer: analysis of surveillance, epidemiology, and end result-medicare data. J Clin Oncol 2011;29:4401-9.
21. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
22. Saltzstein SL, Behling CA. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry. J Clin Gastroenterol 2007;41:173-7.
23. Danish National Board of Health. Recommendations for screening for colorectal cancer. Copenhagen: Danish National Board of Health, 2010.
24. La Vecchia C, Brinton LA, McTiernan A. Menopause, hormone replacement therapy and cancer. Maturitas 2001;39:97-115.
25. Newcomb PA, Zheng Y, Chia VM et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007;67:7534-9.
26. Wallace K, Grau MV, Ahnen D. The association of lifestyle and dietary factors with risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2009;18:2310-7.
27. Kim J, Mittal R, Konyalian V et al. Outcome analysis of patients undergoing colorectal resection for emergent and elective indications. Am Surg 2007;73:991-3.
28. Theme report II: Comorbidity and older cancer patients. 2011. www. DMCG.dk (1 Feb 2012).
29. Iversen LH, Norgaard M, Jacobsen J et al. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study. Dis Colon Rectum 2009;52:71-8.
30. Pheby DF, Levine DF, Pitcher RW et al. Lymph node harvests directly influence the staging of colorectal cancer: evidence from a regional audit. J Clin Pathology 2004;57:43-7.
31. Ratto C, Sofo L, Ippoliti M et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 1999;42:143-54.
32. Bressler B, Pazrat LF, Chen Z et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007; 132:96-102.
33. Leaper M, Johnston MJ, Barclay M et al. Reasons for failure to diagnose colorectal carcinoma at colonoscopy. Endoscopy 2004;36:499-503.
34. Shah HA, Paszat LF, Saskin R et al. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 2007;132:2297-303.
35. Samowitz WS, Curtin K, Ma KN et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkes Prev 2001;10:917-23.
36. Hemminki A, Mecklin JP, Jarvinen H et al. Miscrosatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology 2000;119:921-8.
37. Vasen HF, Moslein G, Alonso A et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genetics 2007;44:353-62.
38. Van Cutsem E, Dicato M, Arber N et al. Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World congress on gastrointestinal cancer, Barcelona 2009. Ann Oncol 2010; 21 Suppl 6:v1-10.